Antibody Conjugation of Nanoparticles as Therapeutics for Breast Cancer Treatment
Breast cancer is the most common invasive tumor in women and the second leading cause of cancer-related death. Nanomedicine raises high expectations for millions of patients as it can provide better, more efficient, and affordable healthcare, and it has the potential to develop novel therapeutics fo...
Main Authors: | Alberto Juan, Francisco J. Cimas, Iván Bravo, Atanasio Pandiella, Alberto Ocaña, Carlos Alonso-Moreno |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-08-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/21/17/6018 |
Similar Items
-
An Overview of Antibody Conjugated Polymeric Nanoparticles for Breast Cancer Therapy
by: Alberto Juan, et al.
Published: (2020-08-01) -
Antibody–Drug Conjugates for the Treatment of Breast Cancer
by: Chiara Corti, et al.
Published: (2021-06-01) -
Impact of the conjugation of antibodies to the surfaces of polymer nanoparticles on the immune cell targeting abilities
by: Na Kyeong Lee, et al.
Published: (2021-08-01) -
Antibody Drug Conjugates as Cancer Therapeutics
by: Pamela A. Trail
Published: (2013-02-01) -
Targeted drug delivery for cancer therapy: the other side of antibodies
by: Firer Michael A, et al.
Published: (2012-11-01)